RTIs A pilot randomized clinical trial (RCT) comparing seven days of dornase alfa to sham therapy in 11 preterm infants aged zero to four months with ventilator-associated RTI found dornase alfa to be safe and associated with an improvement in supplemental O 2 requirement, although this did not reach statistical significance.
1
—
—